SC 13D/A | 2020-04-02 | Access Industries Holdings LLC | Neon Therapeutics, Inc. | 2,153,803 | - | EDGAR |
SC 13D/A | 2020-03-27 | Access Industries Holdings LLC | Neon Therapeutics, Inc. | 2,553,803 | - | EDGAR |
SC 13G | 2020-03-23 | JFL Capital Management LP | Neon Therapeutics, Inc. | 1,519,819 | 5.3% | EDGAR |
SC 13G/A | 2020-02-14 | Partner Fund Management, L.P. | Neon Therapeutics, Inc. | - | 0.0% | EDGAR |
SC 13G/A | 2020-02-07 | FMR LLC | Neon Therapeutics, Inc. | 1,528,496 | 5.4% | EDGAR |
SC 13G/A | 2020-01-27 | WELLINGTON MANAGEMENT GROUP LLP | Neon Therapeutics, Inc. | 0 | 0.0% | EDGAR |
SC 13D | 2020-01-23 | BioNTech SE | Neon Therapeutics, Inc. | 10,407,745 | 36.2% | EDGAR |
SC 13G/A | 2019-02-14 | Partner Fund Management, L.P. | Neon Therapeutics, Inc. | - | 3.5% | EDGAR |
SC 13G | 2019-02-13 | FMR LLC | Neon Therapeutics, Inc. | 2,079,669 | 7.3% | EDGAR |
SC 13G | 2019-02-13 | Third Rock Ventures III, L.P. | Neon Therapeutics, Inc. | 9,741,636 | 34.4% | EDGAR |
SC 13G | 2019-02-12 | WELLINGTON MANAGEMENT GROUP LLP | Neon Therapeutics, Inc. | 2,234,756 | 7.9% | EDGAR |
SC 13D | 2018-07-09 | Access Industries Holdings LLC | Neon Therapeutics, Inc. | 3,097,913 | - | EDGAR |
SC 13G | 2018-07-09 | Partner Fund Management, L.P. | Neon Therapeutics, Inc. | - | 3.5% | EDGAR |